WTAP and ovarian carcinoma: WTAP also promotes the progression of hepatocellular carcinoma via the HuR-ETS proto-oncogene 1 (ETS1) axis [7], and the upregulation of WTAP in ovarian cancer [8] and bladder cancer [9] is associated with poor prognosis.